切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2010, Vol. 04 ›› Issue (03) : 203 -207. doi: 10.3877/cma.j.issn.1674-0793.2010.03.005

所属专题: 文献

论著

手术切除结直肠癌肝多个转移瘤的效果分析
邱际亮1, 元云飞1,(), 李斌奎1, 卢灿亮1, 徐瑞华2, 潘志忠3, 李锦清1, 张亚奇1, 万德森3   
  1. 1. 510060 华南肿瘤学国家重点实验室;中山大学肿瘤防治中心肝胆科
    2. 510060 华南肿瘤学国家重点实验室;中山大学肿瘤防治中心内科
    3. 510060 华南肿瘤学国家重点实验室;中山大学肿瘤防治中心结直肠科
  • 收稿日期:2010-01-25 出版日期:2010-06-01
  • 通信作者: 元云飞

Outcome of hepatectomy for patients with multiple hepatic metastases from colorectal cancer

Ji-liang QIU1, Yun-fei YUAN1,(), Bin-kui LI1, Can-liang LU1, Rui-hua XU2, Zhi-zhong PAN3, Jin-qing LI1, Ya-qi ZHANG1, De-sen WAN3   

  1. 1. Sun Yat-sen University Cancer Center, Guangzhou 510060, China
  • Received:2010-01-25 Published:2010-06-01
  • Corresponding author: Yun-fei YUAN
  • About author:
    Corresponding author: YUAN Yun-fei, Email:
引用本文:

邱际亮, 元云飞, 李斌奎, 卢灿亮, 徐瑞华, 潘志忠, 李锦清, 张亚奇, 万德森. 手术切除结直肠癌肝多个转移瘤的效果分析[J]. 中华普通外科学文献(电子版), 2010, 04(03): 203-207.

Ji-liang QIU, Yun-fei YUAN, Bin-kui LI, Can-liang LU, Rui-hua XU, Zhi-zhong PAN, Jin-qing LI, Ya-qi ZHANG, De-sen WAN. Outcome of hepatectomy for patients with multiple hepatic metastases from colorectal cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(03): 203-207.

目的

对于结直肠癌患者肝内存在多个转移瘤,手术切除的价值存在争议,本文旨在研究手术切除大肠癌肝多个转移瘤的效果。

方法

回顾性分析1996年1月至2006年12月收治的经手术切除的结直肠癌肝转移瘤患者60例,比较肝内单个转移瘤(35例)与多个转移瘤(25例)患者临床和预后资料。

结果

两组均无手术死亡。多个转移瘤组和单个转移瘤组相比,手术并发症为12.0% vs 11.4%(P=1.000);平均住院时间为(14.9±5.1)d vs(15.7±5.8)d(P=0.844);中位生存期为28个月vs 35个月(P=0.089);中位无瘤生存期为16个月vs 19个月(P=0.112);肝内复发率为72.0% vs 51.5%(P=0.109)。多个转移瘤组3、5年总生存率分别是48.4%、30.8%,单个转移瘤组分别为68.6%、57.7%(P=0.165)。

结论

手术切除结直肠癌肝脏多个转移瘤可取得与单个转移瘤相似的效果。手术切除不应视为肝多个转移瘤的禁忌证。术后辅以全身化疗常可以改善预后。

Objective

Survival benefit of resection for multiple liver metastases has not been established. This study was to investigate the effect of resection of multiple hepatic colorectal metastases.

Methods

Sixty patients with liver metastases from colorectal cancer received liver resection from Jan 1996 to Dec 2006, including 25 cases with two or more liver metastases, 35 with solitary liver metastasis. Clinical and outcome data were retrospectively analyzed between multiple liver metastases and solitary liver metastasis.

Results

The perioperative morbidity rate was 12.0% in multiple metastases group and 11.4% in solitary metastasis group (P=1.000), and no mortality in either group. The respective mean hospital duration was (14.9±5.1) days and (15.7±5.8) days (P=0.844), the median overall survival (OS) time was 28 and 35 months (P=0.089), the median disease free survival (DFS) time was 16 and 19 months (P=0.112), and the intrahepatic recurrence rates were 72.0% and 51.5% (P=0.109). The 3- and 5-year overall survival rates were 48.4%, and 30.8%, respectively, in multiple metastases group and 68.6%, 57.7%, respectively, in solitary metastasis group (P=0.165).

Conclusions

There is no significant differences of OS time and DFS time in two groups. Liver resection is not a contraindication for multiple liver metastases. In the current era of effective chemotherapy, aggressive approach with hepatectomy, followed by adjuvant chemotherapy could offer an improved prognosis for multiple liver metastases from colorectal carcinoma.

表1 60例结直肠癌肝转移瘤手术切除的临床资料
图1 单个转移瘤组和多个转移瘤组总生存曲线(A)和无瘤生存曲线(B)
表2 60例结直肠癌肝转移患者的手术治疗结果
1
Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer:a population-based stud.Cancer, 2007, 109(4):718-726.
2
Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg, 1995, 19(1):59-71.
3
Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev, 2008(2):CD006039.
4
Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer:a systematic review of published studies. Br J Cancer, 2006, 94(7):982-999.
5
Shah SA, Bromberg R, Coates A, et al. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg, 2007,205(5):676-683.
6
Cady B, Stone MD, McDermott WV Jr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg, 1992, 127(5):561-568.
7
Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg, 2000, 231(5):743-751.
8
Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases:is there a limit? J Clin Oncol, 2005, 23(33):8490-8499.
9
Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:a randomized GERCOR study. J Clin Oncol, 2004, 22(2):229-237.
10
Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy:does it mean cure?.J Clin Oncol, 2006, 24(24):3939-3945.
11
Kavanaugh DY, Carbone DP.Immunologic dysfunction in cancer. Hematol Oncol Clin North Am, 1996, 10(4):927-951.
12
Tanaka K, Shimada H, Ueda M, et al. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery, 2008, 143(2):259-270.
13
Shimada H, Tanaka K, Masui H, et al. Results of surgical treatment for multiple (> or =5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg, 2004, 389(2):114-121.
14
Lordan JT, Karanjia ND, Quiney N, et al. A 10-year study of outcome following hepatic resection for colorectal liver metastases-The effect of evaluation in a multidisciplinary team setting.Eur J Surg Oncol, 2009, 35(3):302-306.
15
Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection,radiofrequency ablation,and combined resection/ablation for colorectal liver metastases. Ann Surg, 2004, 239(6):818-825.
16
Tanaka K, Shimada H, Nagano Y,et al. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery,2006,139(2):263-273.
17
Antoniou A, Lovegrove RE, Tilney HS, et al. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery, 2007, 141(1):9-18.
18
Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases:the third hepatectomy. Ann Surg, 2003, 238(6):871-883.
19
Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist, 2008, 13(1):51-64.
20
Kornprat P, Jarnagin WR, Gonen M, et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol, 2007, 14(3):1151-1160.
[1] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[2] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[3] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[4] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[5] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[6] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[7] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[8] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[9] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[10] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[11] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[12] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要